Present interferon-based therapy for chronic hepatitis C is limited by both efficacy and tolerability. Telaprevir and boceprevir are the first two direct-acting antiviral drugs (DAAs) that inhibit ...

In adults with chronic hepatitis B infection receiving viral suppression therapy, coupling an investigational small ...

On the 50th anniversary of the discovery of interferon (IFN), we offer a perspective ... and anti-HCV (hepatitis C virus) therapy. They might also have prophylactic or therapeutic effectiveness ...

Motzer and colleagues present updated results from a multicenter, phase III trial of sunitinib versus interferon-α as first-line treatment for patients with metastatic renal-cell carcinoma.

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit ...

treatment-experienced (17) Arm 1: ABT-450/r (250/100 mg) + ABT-333 + RBV × 12 weeks Arm 2: ABT-450/r(150/100 mg) + ABT-333 + RBV × 12 weeks Arm 3: ABT-450/r(150/100 mg) + ABT-333 + RBV × 12 ...

“While 48 weeks of interferon can be used as a standard of care treatment for HBV patients, historically less than 10% of patients experience a functional cure. Here, with the combination of ...

ruzotolimod or pegylated interferon (peginterferon) alfa-2a, in persons who had virologic suppression with NA therapy. We conducted this trial according to the Good Clinical Practice guidelines of ...

"While 48 weeks of interferon can be used as a standard of care treatment for HBV patients, historically less than 10% of patients experience a functional cure. Here, with the combination of imdusiran ...

The first patient received the treatment at Hull Royal Infirmary on Tuesday afternoon. It involves inhaling a protein called interferon beta which the body produces when it gets a viral infection.